Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study

BACKGROUND: We assessed the effect of switching patients with major depressive disorder to milnacipran following an initial selective serotonin reuptake inhibitor treatment failure, and explored potential biomarkers in their blood. METHODS: We conducted a prospective, open-label, 24-week trial. Depr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Tasuku, Sakurai, Daiji, Oda, Yasunori, Hasegawa, Tadashi, Kanahara, Nobuhisa, Sasaki, Tsuyoshi, Komatsu, Hideki, Takahashi, Junpei, Oiwa, Takahiro, Sekine, Yoshimoto, Watanabe, Hiroyuki, Iyo, Masaomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677766/
https://www.ncbi.nlm.nih.gov/pubmed/26677330
http://dx.doi.org/10.2147/NDT.S95067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677766/
https://www.ncbi.nlm.nih.gov/pubmed/26677330
http://dx.doi.org/10.2147/NDT.S95067

Ejemplares similares